Literature DB >> 19566714

TATA box-binding protein gene is associated with risk for schizophrenia, age at onset and prefrontal function.

K Ohi1, R Hashimoto, Y Yasuda, M Kiribayashi, N Iike, T Yoshida, M Azechi, K Ikezawa, H Takahashi, T Morihara, R Ishii, S Tagami, M Iwase, M Okochi, K Kamino, H Kazui, T Tanaka, T Kudo, M Takeda.   

Abstract

Schizophrenia is a common polygenic disease in distinct populations, while spinocerebellar ataxia type 17 (SCA17) is a rare autosomal dominant neurodegenerative disorder. Both diseases involve psychotic symptoms. SCA17 is caused by an expanded polyglutamine tract in the TATA box-binding protein (TBP) gene. In the present study, we investigated the association between schizophrenia and CAG repeat length in common TBP alleles with fewer than 42 CAG repeats in a Japanese population (326 patients with schizophrenia and 116 healthy controls). We found that higher frequency of alleles with greater than 35 CAG repeats in patients with schizophrenia compared with that in controls (p = 0.042). We also examined the correlation between CAG repeats length and age at onset of schizophrenia. We observed a negative correlation between the number of CAG repeats in the chromosome with longer CAG repeats out of two chromosomes and age at onset of schizophrenia (p = 0.020). We further provided evidence that TBP genotypes with greater than 35 CAG repeats, which were enriched in patients with schizophrenia, were significantly associated with hypoactivation of the prefrontal cortex measured by near-infrared spectroscopy during the tower of Hanoi, a task of executive function (right PFC; p = 0.015, left PFC; p = 0.010). These findings suggest possible associations of the genetic variations of the TBP gene with risk for schizophrenia, age at onset and prefrontal function.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19566714     DOI: 10.1111/j.1601-183X.2009.00497.x

Source DB:  PubMed          Journal:  Genes Brain Behav        ISSN: 1601-183X            Impact factor:   3.449


  9 in total

1.  Human brain weight is correlated with expression of the 'housekeeping genes' beta-2-microglobulin (β2M) and TATA-binding protein (TBP).

Authors:  P J Harrison; L M Laatikainen; E M Tunbridge; S L Eastwood
Journal:  Neuropathol Appl Neurobiol       Date:  2010-10       Impact factor: 8.090

2.  Positive symptoms of psychosis correlate with expression of ubiquitin proteasome genes in peripheral blood.

Authors:  Chad A Bousman; Gursharan Chana; Stephen J Glatt; Sharon D Chandler; Todd May; James Lohr; William S Kremen; Ming T Tsuang; Ian P Everall
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-10-05       Impact factor: 3.568

Review 3.  Genomics and pharmacogenomics of schizophrenia.

Authors:  Ramón Cacabelos; Rocío Martínez-Bouza
Journal:  CNS Neurosci Ther       Date:  2010-08-16       Impact factor: 5.243

4.  NRN1 Gene as a Potential Marker of Early-Onset Schizophrenia: Evidence from Genetic and Neuroimaging Approaches.

Authors:  Carmen Almodóvar-Payá; Maria Guardiola-Ripoll; Maria Giralt-López; Carme Gallego; Pilar Salgado-Pineda; Salvador Miret; Raymond Salvador; María J Muñoz; Luisa Lázaro; Amalia Guerrero-Pedraza; Mara Parellada; María I Carrión; Manuel J Cuesta; Teresa Maristany; Salvador Sarró; Lourdes Fañanás; Luis F Callado; Bárbara Arias; Edith Pomarol-Clotet; Mar Fatjó-Vilas
Journal:  Int J Mol Sci       Date:  2022-07-05       Impact factor: 6.208

5.  Decreased white matter FA values in the left inferior frontal gyrus is a possible intermediate phenotype of schizophrenia: evidences from a novel group strategy.

Authors:  Jianjun Ou; Hailong Lyu; Maorong Hu; Jun Li; Wenbin Guo; Xiaofeng Guo; Lihua Li; Junjie Zheng; Qinling Wei; Feng Liu; Zhong He; Juan Wang; Fang Liu; Renrong Wu; Jindong Chen; Lehua Li; Bin Hu; Huafu Chen; Jingping Zhao
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-12-09       Impact factor: 5.270

6.  Impact of the genome wide supported NRGN gene on anterior cingulate morphology in schizophrenia.

Authors:  Kazutaka Ohi; Ryota Hashimoto; Yuka Yasuda; Kiyotaka Nemoto; Takashi Ohnishi; Motoyuki Fukumoto; Hidenaga Yamamori; Satomi Umeda-Yano; Takeya Okada; Masao Iwase; Hiroaki Kazui; Masatoshi Takeda
Journal:  PLoS One       Date:  2012-01-12       Impact factor: 3.240

7.  Glutamate Networks Implicate Cognitive Impairments in Schizophrenia: Genome-Wide Association Studies of 52 Cognitive Phenotypes.

Authors:  Kazutaka Ohi; Ryota Hashimoto; Masashi Ikeda; Hidenaga Yamamori; Yuka Yasuda; Michiko Fujimoto; Satomi Umeda-Yano; Masaki Fukunaga; Haruo Fujino; Yoshiyuki Watanabe; Masao Iwase; Hiroaki Kazui; Nakao Iwata; Daniel R Weinberger; Masatoshi Takeda
Journal:  Schizophr Bull       Date:  2014-12-22       Impact factor: 9.306

8.  The impact of the genome-wide supported variant in the cyclin M2 gene on gray matter morphology in schizophrenia.

Authors:  Kazutaka Ohi; Ryota Hashimoto; Hidenaga Yamamori; Yuka Yasuda; Michiko Fujimoto; Satomi Umeda-Yano; Masaki Fukunaga; Yoshiyuki Watanabe; Masao Iwase; Hiroaki Kazui; Masatoshi Takeda
Journal:  Behav Brain Funct       Date:  2013-10-25       Impact factor: 3.759

Review 9.  Near-infrared spectroscopy in schizophrenia: a possible biomarker for predicting clinical outcome and treatment response.

Authors:  Shinsuke Koike; Yukika Nishimura; Ryu Takizawa; Noriaki Yahata; Kiyoto Kasai
Journal:  Front Psychiatry       Date:  2013-11-14       Impact factor: 4.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.